This inventor holds 1 USPTO granted patent. Top assignee: Plt Patent & License Trading Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Jörg Martin Dormann: Innovator in Dermatological Therapeutics
Introduction
Jörg Martin Dormann is a notable inventor based in Blaustein, Germany. He has made significant contributions to the field of dermatology through his innovative research and development of lipid derivatives. His work focuses on creating therapeutic agents that can improve skin health and treat various dermatological conditions.
Latest Patents
Dormann holds a patent for "Natural semi-synthetic and synthetic lipid derivatives of ceramide and sphingosine groups, drugs and the medical use thereof in the form of therapeutic agents in particular for dermatology." This patent encompasses new substances derived from naturally occurring ceramides and sphingosine, as well as synthetic compounds that share similar structures. These substances include dimers, trimers, and tetramers, which are oligomers of the initial compounds. His innovative approach aims to enhance the efficacy of dermatological treatments.
Career Highlights
Jörg Martin Dormann is associated with Plt Patent & License Trading Ltd., where he continues to advance his research in lipid derivatives. His work has garnered attention for its potential applications in medical therapies, particularly in dermatology. Dormann's dedication to innovation is evident in his patent, which reflects his commitment to improving patient care through scientific advancements.
Collaborations
Dormann collaborates with Hans Uwe Wolf, contributing to the development of new therapeutic agents. Their partnership exemplifies the importance of teamwork in the field of research and innovation.
Conclusion
Jörg Martin Dormann is a pioneering inventor whose work in lipid derivatives has the potential to transform dermatological treatments. His contributions to the field highlight the importance of innovation in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile